Granulomatous adenohypophysitis after interferon and ribavirin therapy
- PMID: 17490932
- DOI: 10.4158/EP.13.2.169
Granulomatous adenohypophysitis after interferon and ribavirin therapy
Abstract
Objective: To describe a case of granulomatous hypophysitis occurring after treatment with interferon alfa-2b and ribavirin for hepatitis C.
Methods: Clinical, radiologic, laboratory, and pathologic assessments of a woman with granulomatous hypophysitis and interferon-induced thyroiditis are presented.
Results: A 42-year-old woman with hepatitis C was treated with interferon alfa-2b and ribavirin for 5 months. She was referred after symptoms of thyrotoxicosis developed, in conjunction with laboratory and radiographic evidence of thyroiditis. During the initial evaluation, she was weak and hypotensive; biochemical evaluation showed undetectable plasma cortisol and corticotropin concentrations. Magnetic resonance imaging revealed diffuse enlargement of the pituitary gland, which encroached on but did not compress the optic chiasm. Treatment with supraphysiologic doses of prednisone resulted in clinical and radiographic improvement. Once physiologic doses of glucocorticoids were instituted, however, follow-up magnetic resonance imaging showed substantial progression of the diffuse pituitary enlargement and mild compression of the optic chiasm. Surgical debulking of the mass and histologic evaluation showed chronic, noncaseating granulomatous hypophysitis. An extensive evaluation for secondary causes of granulomatous inflammation of the pituitary revealed only an elevated angiotensin-converting enzyme level; no organisms were identified. After 2 courses of high-dose glucocorticoids, she had radiographic evidence of decreased size of the pituitary lesion but continued to have multiple anterior pituitary hormone deficiencies.
Conclusion: Granulomatous hypophysitis and sarcoidosis of the pituitary are rare disorders. Hypophysitis should be considered in patients receiving interferon and ribavirin therapy who have symptoms consistent with pituitary dysfunction.
Similar articles
-
Central hypothyroidism and hypophysitis during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin.Eur J Gastroenterol Hepatol. 2006 Jun;18(6):693-4. doi: 10.1097/00042737-200606000-00019. Eur J Gastroenterol Hepatol. 2006. PMID: 16702862
-
[A case of peripheral facial nerve palsy with cryoglobulinemia and chronic thyroiditis occurring during interferon plus ribavirin therapy for chronic hepatitis C].Nihon Shokakibyo Gakkai Zasshi. 2007 Jun;104(6):815-21. Nihon Shokakibyo Gakkai Zasshi. 2007. PMID: 17548949 Japanese.
-
Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C--a case report and review of the literature.Acta Gastroenterol Belg. 2005 Oct-Dec;68(4):432-4. Acta Gastroenterol Belg. 2005. PMID: 16432996 Review.
-
[Ischemic anterior optic neuropathy complicating interferon alpha-2a and ribavirin treatment for acute hepatitis C].Gastroenterol Clin Biol. 2005 May;29(5):616-7. doi: 10.1016/s0399-8320(05)82144-x. Gastroenterol Clin Biol. 2005. PMID: 15980766 French. No abstract available.
-
Peginterferon-alpha(2b) and ribavirin.Expert Rev Anti Infect Ther. 2004 Feb;2(1):17-25. doi: 10.1586/14787210.2.1.17. Expert Rev Anti Infect Ther. 2004. PMID: 15482168 Review.
Cited by
-
IgG4-related hypophysitis: a new addition to the hypophysitis spectrum.J Clin Endocrinol Metab. 2011 Jul;96(7):1971-80. doi: 10.1210/jc.2010-2970. Epub 2011 May 18. J Clin Endocrinol Metab. 2011. PMID: 21593109 Free PMC article.
-
[Differential diagnosis and tactics of managing a patient with primary hypophysitis on the example of a clinical case].Probl Endokrinol (Mosk). 2024 Jan 24;69(6):54-62. doi: 10.14341/probl13311. Probl Endokrinol (Mosk). 2024. PMID: 38311995 Free PMC article. Russian.
-
Necrotizing infundibuloneurohypophysitis: case report and literature review.Endocr Pathol. 2012 Sep;23(3):205-11. doi: 10.1007/s12022-012-9214-y. Endocr Pathol. 2012. PMID: 22661312 Review. No abstract available.
-
Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights.Pituitary. 2016 Feb;19(1):82-92. doi: 10.1007/s11102-015-0671-4. Pituitary. 2016. PMID: 26186958 Review.
-
Inhibition of IRAK1 Is an Effective Therapy for Autoimmune Hypophysitis in Mice.Int J Mol Sci. 2022 Nov 29;23(23):14958. doi: 10.3390/ijms232314958. Int J Mol Sci. 2022. PMID: 36499283 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical